Since 1986, when MDA-funded researchers identified the gene that, when flawed, leads to Duchenne muscular dystrophy (DMD), scientists have been actively pursuing treatments and cures. In the past 12 months, MDA has awarded research grants to the following individuals who are building on the strong foundation of previous research and discovery to better understand — and someday cure — the diseases.

Dean Burkin was awarded an MDA research grant to test the effects of an existing FDA-approved drug on the function of heart and skeletal muscle in a mouse model of DMD.

Feng Yue, of Purdue University was awarded an MDA development grant totaling more than $175,000 over three years to evaluate the therapeutic potential of a protein called PTEN in DMD.